Alport syndrome

Kidney International

Volumn 50, Issue 5, 1996, Pages 1445-1463

  Kashtan, C E ^a   Michael, A F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALPORT SYNDROME; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029904984     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.459     Document Type: Article

References (186)

1. ALPORT AC: Hereditary familial congenital haemorrhagic nephritis. Br Med J 1:504-506, 1927
2. SPEAR GS: Alport's syndrome: A consideration of pathogenesis. Clin Nephrol 1:336-337, 1973
3. VANDENBERG P, KERN A, RIES A, LUCKENBILL-EDDS L, MANN K, KUHN K: Characterization of a type IV collagen major cell binding site with affinity to the α1β1 and α2β1 integrins. J Biol Chem 113:1475-1483, 1991
4. KRISHNAMURTI U, CHEN Y, MICHAEL A, FAN WW, WIESLANDER J, JOHANSSON C, RONDEAU E, DELARUE F, TSILIBARY EC: Integrin-mediated interactions between primary/T-SV40 immortalized human glomerular epithelial cells and type IV collagen. Lab Invest (in press)
5. LEINONEN A, MARIYAMA M, MOCHIZUKI T, TRYGGVASON T, REEDERS ST: Complete primary structure of the human type IV collagen α4(IV) chain. J Biol Chem 269:26172-26177, 1994
6. TIMPL R, WIEDEMANN H, VAN DELDEN V, FURTHMAYR H, KUHN K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120:203-211, 1981
7. TSILIBARY E, CHARONIS A: The role of the main noncollagenous domain (NC1) in type IV collagen self-assembly. J Cell Biol 103: 2467-2473, 1986
8. AUMAILLEY M, TIMPL R: Attachment of cells to basement membrane collagen type IV. J Cell Biol 103:1569-1575, 1986
9. CHARONIS AS, TSILIBARY EC, YURCHENCO PD, FURTHMAYR H: Binding of laminin to type IV collagen: A morphological study. J Cell Biol 100:1848-1853, 1985
10. YURCHENCO PD, TSILIBARY EC, CHARONIS AS, FURTHMAYR H: Models for the self-assembly of basement membrane. J Histochem Cytochem 34:93-102, 1986
11. ZHOU J, DING M, ZHAO Z, REEDERS ST: Complete primary structure of the sixth chain of human basement membrane collagen, α6(IV). J Biol Chem 269:13193-13199, 1994
12. BOYD CD, TOTH-FEJEL S, GADI IK, LITT M, CONDON MR, KOLBE M, HAGEN IK, KURKINEN M, MACKENZIE JW, MAGENIS E: The genes coding for human pro alpha 1(IV) and pro alpha 2(IV) collagen are both located at the end of the long arm of chromosome 13. Am J Hum Genet 42:309-314, 1988
13. MARIYAMA M, ZHENG K, YANG-FENG TL, REEDERS ST: Colocalization of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 13:809-813, 1992
14. MYERS JC, JONES TA, POHJOLAINEN E-R, KADRI AS, GODDARD AD, SHEER D, SOLOMON E, PIHLAJANIEMI T: Molecular cloning of α5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. Am J Hum Genet 46:1024-1033, 1990
15. HOSTIKKA SL, EDDY RL, BYERS MG, HOYHTYA M, SHOWS TB, TRYGGVASON K: Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 87:1606-1610, 1990
16. FISCHER G, SCHMIDT C, OPITZ J, CULLY Z, KUHN K, POSCHL E: Identification of a novel sequence element in the common promoter region of human collagen type IV genes, involved in the regulation of divergent transcription. Biochem J 292:687-695, 1993
17. SCHMIDT C, POLLNER R, POSCHL E, KUHN K: Expression of human collagen type IV genes is regulated by transcriptional and post-transcriptional mechanisms. FEBS Lett 312:174-178, 1992
18. BRUGGEMAN LA, BURBELO PD, YAMADA Y, KLOTMAN PE: A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor. Oncogene 7:1497-1502, 1992
19. POSCHL E, POLLNER R, KUHN K: The genes for the α1(IV) and α2(IV) chains of human basement membrane collagen type IV are arranged head-to-head and separated by a bidirectional promoter of unique structure. EMBO J 7:2687-2695, 1988
20. HANIEL A, WELGE-LUBEN U, KUHN K, POSCHL E: Identification and characterization of a novel transcriptional silencer in the human collagen type IV gene COL4A2. J Biol Chem 270:11209-11215, 1995
21. HLAING T, FUNABIKI K, TOGAWA M, CHAPO JA, KILLEN PD: Molecular cloning of the murine α3(IV) and α4(IV) collagen promoter. (abstract) J Am Soc Nephrol 5:625, 1994
22. SUGIMOTO M, OOHASHI T, NINOMIYA Y: The genes COL4A5 and COL4A6, coding for basement membrane collagen chains α5(IV) and α6(IV), are located head-to-head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Proc Natl Acad Sci USA 91:11679-11683, 1994
23. PENADES JR, BERNAL D, REVERT F, JOHANSSON C, FRESQUET VJ, CERVERA J, WIESLANDER J, QUINONES S, SAUS J: Characterization and expression of multiple alternatively spliced transcripts of the Goodpasture antigen gene region. Eur J Biochem 229:754-760, 1995
24. BUTKOWSKI RJ, WIESLANDER J, KLEPPEL M, MICHAEL AF, FISH AJ: Basement membrane collagen in the kidney: Regional localization of novel chains related to collagen IV. Kidney Int 35:1195-1202, 1989
25. KLEPPEL MM, KASHTAN C, SANTI PA, WIESLANDER J, MICHAEL AF: Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab Invest 61:278-289, 1989
26. KLEPPEL MM, SANTI PA, CAMERON JD, WIESLANDER J, MICHAEL AF: Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813-825, 1989
27. KLEPPEL MM, MICHAEL AF: Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat 187:165-174, 1990
28. PEISSEL B, GENG L, KALLURI R, KASHTAN C, RENNKE HG, GALLO GR, YOSHIOKA K, SUN MJ, HUDSON BG, NEILSON EG, ZHOU J: Comparative distribution of the α1(IV). α5(IV) and α5(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96:1948-1957, 1995
29. NINOMIYA Y, KAGAWA M, IYAMA K, NAITO I, KISHIRO Y, SEYER JM, SUGIMOTO M, OOHASHI T, SADO Y: Differential expression of two basement membrane collagen genes. COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 130:1219-1229, 1995
30. KIM Y, KLEPPEL MM, BUTKOWSKI R, MAUER SM, WIESLANDER J, MICHAEL AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
31. KIM Y, BUTKOWSKI R, BURKE B, KLEPPEL MM, CROSSON J, KATZ A, MICHAEL AF: Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 139:1381-1388, 1991
32. YOSHIOKA K, HINO S, TAKEMURA T, MAKI S, WIESLANDER J, TAKEKOSHI Y, MAKINO H, KAGAWA M, SADO Y, KASHTAN CE: Type IV collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144:986-996, 1994
33. KLEPPEL MM, FAN WW, CHEONG HI, MICHAEL AF: Evidence for separate networks of classical and novel basement membrane collagen: Characterization of α3(IV)-Alport antigen heterodimers. J Biol Chem 267:4137-4142, 1992
34. JOHANSSON C, BUTKOWSKI R, WIESLANDER J: The structural organization of type IV collagen. Identification of three NC1 populations in the glomerular basement membrane. J Biol Chem 267:24533-24537, 1992
35. WIESLANDER J, BARR JF, BUTKOWSKI R, EDWARDS SJ, BYGREN P, HEINEGARD D, HUDSON BG: Goodpasture antigen of the glomerular basement membrane: Localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 81:3838-3842, 1984
36. BUTKOWSKI RJ, LANGEVELD JPM, WEISLANDER J, HAMILTON J, HUDSON BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 262:7874-7877, 1987
37. SAUS J, WIESLANDER J, LANGEVELD JPM, QUINONES S, HUDSON BG: Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 263:13374-13380, 1988
38. KALLURI R, GUNWAR S, REEDERS ST, MORRISON KC, MARIYAMA M, EBNER KE, NOELKEN ME, HUDSON BG: Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the α3(IV) chain of basement membrane collagen. J Biol Chem 266:24018-24024, 1991
39. FEINGOLD J, BOIS E, CHOMPRET A, BROYER M, GUBLER MC, GRUNFELD JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27:672-677, 1985
40. MCNEILL WM, ATKIN CL, BLOOMER HA: Hereditary nephritis: A re-examination of its clinical and genetic features. Ann Intern Med 88:176-182, 1978
41. HASSTEDT SJ, ATKIN CL: X-linked inheritance of Alport syndrome: Family P revisited. Am J Hum Genet 35:1241-1251, 1983
42. ATKIN CL, HASSTEDT SJ, MENLOVE L, CANNON L, KIRSCHNER N, SCHWARTZ C, NGUYEN K, SKOLNICK M: Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 42:249-255, 1988
43. FLINTER FA, CAMERON JS, CHANTLER C, HOUSTON I, BOBROW M: Genetics of classic Alport's syndrome. Lancet ii:1005-1007, 1988
44. BRUNNER H, SCHRODER C, VAN BENNEKOM C, LAMBERMON E, TUERLINGS J, MENZEL D, OLBING H, MONNENS L, WIERINGA B, ROPERS H-H: Localization of the gene for X-linked Alport's syndrome. Kidney Int 34:507-510, 1988
45. KASHTAN CE, RICH SS, MICHAEL AF, DE MARTINVILLE B: Gene mapping in Alport families with different basement membrane antigenic phenotypes. Kidney Int 38:925-930, 1990
46. SZPIRO-TAPIA S, BOBRIE G, GOUILLOUD-BATAILLE M, HEUERTZ S, JULIER C, FREZAL J, GRUNFELD JP, HORS-CAYLA MC: Linkage studies in X-linked Alport's syndrome. Hum Genet 81:85-87, 1988
47. PIHLAJANIEMI T, POHJOLAINEN E-R, MYERS JC: Complete primary structure of the triple-helical region and the carboxyl-terminal domain of a new type IV collagen chain, α5(IV). J Biol Chem 265:13758-13766, 1990
48. BARKER DF, HOSTIKKA SL, ZHOU J, CHOW LT, OLIPHANT AR, GERKEN SC, GREGORY MC, SKOLNICK MH, ATKIN CL: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
49. GAUTHIER B, KASHTAN CE: Hereditary nephropathies, in Current Nephrology, edited by GONICK HC, St. Louis, Mosby-Year Book, Inc., 1995, pp 127-168
50. ZHOU J, MOCHIZUKI T, SMEETS H, ANTIGNAC C, LAURILA P, DE PAEPE A, TRYGGVASON K, REEDERS ST: Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261:1167-1169, 1993
51. RENIERI A, BRUTTINI M, GALLI L, ZANELLI P, NERI T, ROSSETTI S, TURCO A, HEISKARI N, ZHOU J, GUSMANO R, MASSELLA L, BANFI G, SCOLARI F, SESSA A, RIZZONI G, TRYGGVASON K, PIGNATTI PF, SAVI M, BALLABIO A, DE MARCHI M: X-linked Alport syndrome: An SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 58:1192-1204, 1996
52. KAWAI S, NOMURA S, HARANO T, HARANO K, FUKUSHIMA T, OSAWA G: The COL4A5 gene in Japanese Alport syndrome patients: Spectrum of mutations of all exons. Kidney Int 49:814-822, 1996
53. LAMBRECHT R, SEIBOLD S, LEINONEN A, WEBER M: The intragenic region between the collagen genes COL4A5 and COL4A6 is probably not affected in Alport syndrome: A study with 110 families. (abstract) J Am Soc Nephrol 6:723, 1995
54. SMEETS HJM, MELENHORST JJ, LEMMINK HH, SCHRODER CH, NELEN MR, ZHOU J, HOSTIKKA SL, TRYGGVASON K, ROPERS H-H, JANSWEIJER MCE, MONNENS LAH, BRUNNER HG, VAN OOST BA: Different mutations in the COL4A5 collagen gene in two patients with different features of Alport syndrome. Kidney Int 42:83-88, 1992
55. NETZER K-O, RENDERS L, ZHOU J, PULLIG O, TRYGGVASON K, WEBER M: Deletions of the COL4A5 gene in patients with Alport syndrome. Kidney Int 42:1336-1334, 1992
56. RENIERI A, SERI M, MYERS JC, PIHLAJANIEMI T, SESSA A, RIZZONI G, DE MARCHI M: Alport syndrome cause by a 5′ deletion within the COL4A5 gene. Hum Genet 89:120-121, 1992
57. BOYE E, VETRIE D, FLINTER F, BUCKLE B, PIHLAJANIEMI T, HAMALAINEN E-R, MYERS JC, BOBROW A, HARRIS A: Major rearrangements in the alpha-5(IV) gene in three patients with Alport syndrome. Genomics 11:1125-1132, 1991
58. ANTIGNAC C, KNEBELMANN B, DRUOUT L, GROS F, DESCHENES G, HORS-CAYLA M-C, ZHOU J, TRYGGVASON K, GRUNFELD J-P, BROYER M, GUBLER M-C: Deletions in the COL4A5 collagen gene in X-linked Alport syndrome: Characterization of the pathological transcripts in non-renal cells and correlation with disease expression. J Clin Invest 93:1195-1207, 1994
59. ANTIGNAC C, ZHOU J, SANAK M, COCHAT P, ROUSSEL B, DESCHENES G, GROS F, KNEBELMANN B, HORS-CAYLA M-C, TRYGGVASON K, GUBLER M-C: Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 gene. Kidney Int 42:1178-1183, 1992
60. HEIDET L, DAHAN K, ZHOU J, XU Z, COCHAT P, GOULD JDM, LEPPIG KA, PROESMANS W, GUYOT C, GUILLOT M, ROUSSEL B, TRYGGVASON K, GRUNFELD JP, GUBLER MC, ANTIGNAC C: Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumors. Hum Mol Genet 4:99-108, 1995
61. ZHOU J, HERTZ JM, LEINONEN A, TRYGGVASON K: Complete amino acid sequence of the human α5(IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. J Biol Chem 267:12475-12481, 1992
62. KNEBELMANN B, DESCHENES G, GROS F, HORS M-C, GRUNFELD J-P, TRYGGVASON K, GUBLER M-C, ANTIGNAC C: Substitution of arginine for glycine 325 in the collagen α5(IV) chain associated with X-linked Alport syndrome: Characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet 51:135-142, 1992
63. RENIERI A, MERONI M, SESSA A, AL E: Variability of clinical phenotype in a large Alport family with gly1143-ser change of collagen α5(IV) chain. Nephron 67:444-449, 1994
64. RENIERI A, SERI M, MYERS JC, PIHLAJANIEMI T, MASSELLA L, RIZZONI G, DE MARCHI M: De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome. Hum Mol Gen 1:127-129, 1992
65. ZHOU J, HERTZ JM, TRYGGVASON K: Mutation in the α5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: Detection by denaturing gradient gel electrophoresis of a PCR product. Am J Hum Genet 50:1291-1300, 1992
66. KUIVANIEMI H, TROMP G, PROCKOP DJ: Mutations in collagen genes: Causes of rare and some common diseases in humans. FASEB J 5:2052-2060, 1991
67. SIBLEY MH, GRAHAM PL, VON MENDE N, KRAMER JM: Mutations in the α2(IV) basement membrane collagen gene of Caenorhabditis elegans produce phenotypes of differing severities. EMBO J 13:3278-3285, 1994
68. ZHOU J, BARKER DF, HOSTIKKA SL, GREGORY MC, ATKIN CL, TRYGGVASON K: Single base mutation in α5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9:10-18, 1991
69. ZHOU J, GREGORY MC, HERTZ JM, BARKER DF, ATKIN C, SPENCER ES, TRYGGVASON K: Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport syndrome. Kidney Int 43:722-729, 1993
70. LEMMINK HH, SCHRODER CH, BRUNNER HG, NELEN MR, ZHOU J, TRYGGVASON K, HAAGSMA-SCHOUTEN WAG, ROODVOETS AP, RASCHER W, VAN OOST BA, SMEETS HJM: Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics 17:485-489, 1993
71. NETZER K-O, PULLIG O, FREI U, ZHOU J, TRGGVASON K, WEBER M: COL4A5 splice site mutation and α5(IV) collagen mRNA in Alport syndrome. Kidney Int 43:486-492, 1993
72. NOMURA S, OSAWA G, SAI T, HARANO T, HARANO K: A splicing mutation in the α5(IV) gene of a family with Alport's syndrome. Kidney Int 43:1116-1124, 1993
73. RENIERI A, SERI M, GALLI L, COSCI P, IMBASCIATI E, MASSELLA L, RIZZONI G, RESTAGNO G, CARBONARA AO, STRAMIGNONI E, BASOLO B, PICCOLI G, DE MARCHI M: Small frameshift deletions within the COL4A5 gene in juvenile-onset Alport syndrome. Hum Genet 92:417-420, 1993
74. BOYE E, FLINTER FA, BOBROW M, HARRIS A: An 8 bp deletion in exon 51 of the COL4A5 gene of an Alport syndrome patient. Hum Mol Genet 2:595-596, 1993
75. RENIERI A, GALLI L, SERI M, AL E: Alport syndrome in Italy: A multicenter screening for COL4A5 gene mutations. (abstract) Am J Hum Genet 53:1219, 1993
76. KNEBELMANN B, BENESSY F, BUEMI M, GRUNFELD JP, GUBLER MC, ANTIGNAC C: Autosomal recessive (AR) inheritance in Alport syndrome (AS). (abstract) J Am Soc Nephrol 4:263, 1993
77. MOCHIZUKI T, LEMMINK HH, MARIYAMA M, ANTIGNAC C, GUBLER MC, PIRSON Y, VERELLEN-DUMOULIN C, CHAN B, SCHROEDER CH, SMEETS HJM, REEDERS ST: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nature Genet 8:77-82, 1994
78. LEMMINK HH, MOCHIZUKI T, VAN DEN HEUVEL LPWJ, SCHRODER CH, BARRIENTOS A, MONNENS LAH, VAN OOST BA, BRUNNER HG, REEDERS ST, SMEETS HJM: Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3:1269-1273, 1994
79. DING J, STITZEL J, BERRY P, HAWKINS E, KASHTAN C: Autosomal recessive Alport syndrome: Mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:1714-1717, 1995
80. KNEBELMANN B, FORESTIER L, DROUOT L, QUINONES S, CHUET C, BENESSY F, SAUS J, ANTIGNAC C: Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4:675-679, 1995
81. NAKAZATO H, HATTORI S, USHIJIMA T, MATSUURA T, KOITABASHI Y, TAKADA T, YOSHIOKA K, ENDO F, MATSUDA I: Mutations in the COL4A5 gene in Alport syndrome: A possible mutation in primordial germ cells. Kidney Int 46:1307-1314, 1994
82. PIEZ KA: Molecular and aggregate structures of the collagens, in Extracellular Matrix Biochemistry, edited by PIEZ KA, REDDI AH, New York, Elsevier, 1984, pp 1-39
83. WESTERHAUSEN A, KISHI J, PROCKOP DJ: Mutations that substitute serine for glycine α1-598 and glycine α1-631 in type I procollagen: the effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks. J Biol Chem 265:13995-14000, 1990
84. MCCOY RC, JOHNSON HK, STONE WJ, WILSON CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21:642-652, 1982
85. OLSON DL, ANAND SK, LANDING BH, HEUSER E, GRUSHKIN CM, LIEBERMAN E: Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies. J Pediatr 96:697-699, 1980
86. KASHTAN C, FISH AJ, KLEPPEL M, YOSHIOKA K, MICHAEL AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78:1035-1044, 1986
87. JERAJ K, KIM Y, VERNIER RL, FISH AJ, MICHAEL AF: Absence of Goodpasture's antigen in male patients with familial nephritis. Am J Kid Dis 2:626-629, 1982
88. SAVAGE COS, PUSEY CD, KERSHAW MJ, CASHMAN SJ, HARRISON P, HARLEY B, TURNER DR, CAMERON JS, EVANS DJ, LOCKWOOD CM: The Goodpasture antigen in Alport's syndrome: Studies with a monoclonal antibody. Kidney Int 30:107-112, 1986
89. JENIS EH, VALESKI JE, CALCAGNO PL: Variability of anti-GBM binding in hereditary nephritis. Clin Nephrol 15:111-114, 1981
90. KASHTAN CE, KIM Y: Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126, 1992
91. NAKANISHI K, YOSHIKAWA N, IIJIMA K, KITAGAWA K, NAKAMURA H, ITO H, YOSHIOKA K, KAGAWA M, SADO Y: Immunohistochemical study of α1-5 chains of type IV. collagen in hereditary nephritis. Kidney Int 46:1413-1421, 1994
92. KASHTAN CE, ATKIN CL, GREGORY MC, MICHAEL AF: Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney Int 36:669-674, 1989
93. CHEONG HI, KASHTAN CE, KIM Y, KLEPPEL MM, MICHAEL AF: Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Invest 70:553-557, 1994
94. GUBLER MC, KNEBELMANN B, BEZIAU A, BROYER M, PIRSON Y, HADDOUM F, KLEPPEL MM, ANTIGNAC C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147, 1995
95. REEDERS ST: Molecular genetics of hereditary nephritis. Kidney Int 42:783-792, 1992
96. KLEPPEL MM, KASHTAN CE, BUTKOWSKI RJ, FISH AJ, MICHAEL AF: Alport familial nephritis: Absence of 28 kD non-collagenous monomers of type IV collagen in glomerular basement membrane. J Clin Invest 80:263-266, 1987
97. THORNER PS, ZHENG K, KALLURI R, JACOBS R, HUDSON BG: Coordinate gene expression of the α3, α4 and α5 chains of collagen type IV: Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271:13821-13828, 1996
98. ZHENG K, THORNER PS, MARRANO P, BAUMAL R, MCINNES RR: Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagentype IV. Proc Natl Acad Sci USA 91:3989-3993, 1994
99. PROCKOP DJ: Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 326:540-546, 1992
100. BROWNELL RD, WOLTER JR: Anterior lenticonus in familial hemorrhagic nephritis: Demonstration of lens pathology. Arch Ophthalmol 71:481-483, 1964
101. STREETEN BW, ROBINSON MR, WALLACE R, JONES DB: Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 105:1693-1697, 1987
102. NOAKES PG, MINER JH, GAUTAM M, CUNNINGHAM JM, SANES JR, MERLIE JP: The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1. Nature Genet 10:400-406, 1995
103. GUBLER M, LEVY M, BROYER M, NAIZOT C, GONZALES G, PERRIN D, HABIB R: Alport's syndrome: A report of 58 cases and a review of the literature. Am J Med 70:493-505, 1981
104. ANTONOVYCH TT, DEASY PF, TINA LU, D'ALBORA JB, HOLLERMAN CE, CALCAGNO PL: Hereditary nephritis: Early clinical, functional and morphological studies. Pediatr Res 3:545-556, 1969
105. TISHLER PV: Healthy female carriers of a gene for the Alport syndrome: Importance for genetic counseling. Clin Genet 16:291-294, 1979
106. RUMPELT H-J: Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13:203-207, 1980
107. TISHLER PV, ROSNER B: The genetics of the Alport syndrome. Birth Defects 10:93-99, 1974
108. HASSTEDT SJ, ATKIN CL, SAN JUAN AC: Genetic heterogeneity among kindreds with Alport syndrome. Am J Hum Genet 38:940-953, 1986
109. GREGORY MC, ATKIN CL: Alport syndrome, in Diseases of the Kidney, edited by SCHRIER RW, GOTTSCHALK CW, Boston, Little, Brown, 1993, pp 571-591
110. GRUNFELD J-P, NOEL LH, HAFEZ S, DROZ D: Renal prognosis in women with hereditary nephritis. Clin Nephrol 23:267-271, 1985
111. WESTER DC, ATKIN CL, GREGORY MC: Alport syndrome: Clinical update. J Am Acad Audiol 6:73-79, 1995
112. GRUNFELD J-P: The clinical spectrum of hereditary nephritis. Kidney Int 27:83-92, 1985
113. GLEESON MJ: Alport's syndrome: Audiological manifestations and implications. J Laryngol Otol 98:449-465, 1984
114. PAULER M, SCHUKNECHT HF, WHITE JA: Atrophy of the stria vascularis as a cause of sensorineural hearing loss. Laryngoscope 98:754, 1981
115. JOHNSSON L-G, ARENBERG IK: Cochlear abnormalities in Alport's syndrome. Arch Otolaryngol 107:340-349, 1981
116. ARNOLD W: Uberlegungen zur Pathogenese des cochleorenalen Syndromes. Acta Otolaryngol 89:330-341, 1980
117. CHANCE JK, STANLEY JA: Alport's syndrome: Case report and review of ocular manifestations. Ann Ophthalmol 9:1527-1530, 1977
118. PERRIN D, JUNGERS P, GRUNFELD JP, DELONS S, NOEL LH, ZENATTI C: Perimacular changes in Alport's syndrome. Clin Nephrol 13:163-167, 1980
119. NIELSEN CE: Lenticonus anterior and Alport's syndrome. Arch Ophthalmol 56:518-530, 1978
120. ARNOTT EJ, CRAWFURD MD, TOGHILL PJ: Anterior lenticonus and Alport's syndrome. Br J Ophthalmol 50:390-403, 1966
121. GOVAN JAA: Ocular manifestations of Alport's syndrome: A hereditary disorder of basement membranes. Br J Ophthalmol 67:493-503, 1983
122. GREGG JB, BECKER SJ: Concomitant progressive deafness, chronic nephritis and ocular lens disease. Arch Ophthalmol 69:293-299, 1963
123. POLACK BCP, HOGEWIND BL: Macular lesions in Alport's disease. Am J Ophthalmol 84:533-535, 1977
124. SABATES R, KRACHMER JH, WEINGEIST TA: Ocular findings in Alport's syndrome. Ophthalmologica 186:204-210, 1983
125. ZYLBERMAN R, SILVERSTONE B-Z, BRANDES E, DRUKKER A: Retinal lesion in Alport's syndrome. J Pediatr Ophthalmol 17:255-260, 1980
126. THOMPSON SM, DEADY JP, WILLSHAW HE, WHITE RHR: Ocular signs in Alport's syndrome. Eye 1:146-153, 1987
127. TEEKHASAENEE C, NIMMANIT S, WUTTHIPHAN S, VAREESANGTHIP K, LAOHAPAND T, MALASITR P, RITCH R: Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology 98:1207-1215, 1991
128. GARCIA TORRES R, GUARNER V: Leiomiomatosis del esofago, traqueo bronquial y genital asociada con negropatia hereditaria tipo Alport: Un nuevo syndrome. Rev Gastroenterol Mex 70:163-170, 1983
129. ROUSSEL B, BIREMBAUT P, GAILLARD D, PUCHELLE JC, D'ALBIGNAC G, PENNAFORTE F, FANDRE M: Leiomyomatose aesophagienne familiale associee a un syndrome d'Alport chez un garcon de 9 ans. Helv Paediat Acta 41:359-368, 1986
130. COCHAT P, GUIBAD P, GARCIA TORRES R, ROUSSEL B, GUARNER V, LARBRE F: Diffuse leiomyomatosis in Alport syndrome. J Pediatr 113:339-343, 1988
131. LEGIUS E, PROESMANS W, VAN DAMME B, GEBOES K, LERUT T, EGGERMONT E: Muscular hypertrophy of the oesophagus and "Alport-like" glomerular lesions in a boy. Eur J Pediatr 149:623-627, 1990
132. DAHAN K, HEIDET L, ZHOU J, METTLER G, LEPPIG K, PROESMANS W, DAVID A, ROUSSEL B, MONGEAU JG, GOULD JMD, GRUNFELD J-P, GUBLER M-C, ANTIGNAC C: Smooth muscle tumors associated with X-linked Alport syndrome: Carrier detection in females. Kidney Int 48:1900-1906, 1995
133. EPSTEIN CJ, SAHUD MA, PIEL CF, GOODMAN JR, BERNFIELD MR, KUSHNER JH, ABLIN AR: Hereditary macrothrombocytopenia, nephritis and deafness. Am J Med 52:299-310, 1972
134. CLARE NM, MONTIEL MM, LIFSCHITZ MD, BANNAYAN GA: Alport's syndrome associated with macrothrombocytopenic thrombocytopenia. Am J Clin Pathol 72:111-117, 1979
135. PARSA KP, LEE DBN, ZAMBONI L, GLASSOCK RJ: Hereditary nephritis, deafness and abnormal thrombopoiesis: Study of a new kindred. Am J Med 60:665-671, 1976
136. ECKSTEIN JD, FILIP DJ, WATTS JC: Hereditary thrombocytopenia, deafness, and renal disease. Ann Intern Med 82:639-645, 1975
137. BERHEIM J, DECHAVANNE M, BRYON PA, LAGARDE M, COLON S, POZET N, TRAEGER J: Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med 61:145-150, 1976
138. HANSEN MS, BEHNKE O, PEDERSEN NT, VIDEBAEK A: Macrothrombocytopenia associated with glomerulonephritis, deafness and aortic cystic medianecrosis. Scand J Hematol 21:197-205, 1978
139. ALVING BM, TARASOFF PG, MOORE J, LEISSENGER CA, FERNANDEZ-BUENO C: Successful renal transplantation for Epstein syndrome. Am J Hematol 21:111-113, 1986
140. PETERSON LC, RAO KV, CROSSON JT, WHITE JG: Fechtner syndrome: A variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopathia. Blood 65:397-406, 1985
141. BRIVET F, GIROT R, BARBANEL C, MAIER M, CROSNIER J: Hereditary nephritis associated with May-Hegglin anomaly. Nephron 29:59-62, 1981
142. KASHTAN CE, SIBLEY RK, MICHAEL AF, VERNIER RL: Hereditary nephritis: Alport syndrome and thin glomerular basement membrane disease, in Renal Pathology, edited by TISHER CC, BRENNER BM, Philadelphia, J.B. Lippincott, 1994, pp 1239-1267
143. YOSHIKAWA N, MATSUYAMA S, ITO H, HAJIKANO H, MATSUO T: Nonfamilial hematuria associated with glomerular basement membrane alterations characteristic of hereditary nephritis: Comparison with hereditary nephritis. J Pediatr 111:519-524, 1987
144. BOHRER N, CHURG J, GRIBETZ D: Glomerulonephritis in two sets of identical twins. Am J Med 36:787-794, 1964
145. KINOSHITA Y, MORITA T, WADA J, WATANABE M, OSAWA G, KOBAYASHI N, EBE T, MUROHASHI K, MUROYAMA M: Hereditary chronic nephritis (Alport) complicated by nephrotic syndrome. Acta Med Biol 17:101-117, 1969
146. SPEAR GS, SLUSSER RJ: Alport's syndrome: Emphasizing electron microscopic studies of the glomerulus. Am J Pathol 69:213-222, 1972
147. HINGLAIS N, GRUNFELD J-P, BOIS LE: Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest 27:473-487, 1972
148. CHURG J, SHERMAN RL: Pathologic characteristics of hereditary nephritis. Arch Pathol 95:374-379, 1973
149. GABOARDI F, EDEFONTI A, IMBASCIATI E, TARENTINO A, MIHATSCH MJ, ZOLLINGER HU: Alport's syndrome (progressive hereditary nephritis). Clin Nephrol 2:143-156, 1974
150. RUMPELT H-J, LANGER KH, SCHARER K, STRAUB E, THEONES W: Split and extremely thin glomerular basement membranes in hereditary nephropathy (Alport's syndrome). Virchow's Arch A 364:225-233, 1974
151. SPEAR GS: Pathology of the kidney in Alport's syndrome. Pathol Annual 9:93-138, 1974
152. RUMPELT H-J: Alport's syndrome: Specificity and pathogenesis of glomerular basement membrane alterations. Pediatr Nephrol 1:422-427, 1987
153. YOSHIKAWA N, WHITE RHR, CAMERON AH: Familial hematuria: Clinicopathological correlations. Clin Nephrol 17:172-182, 1982
154. PIEL CF, BIAVA CG, GOODMAN JR: Glomerular basement membrane attenuation in familial nephritis and "benign" hematuria. J Pediatr 101:358-365, 1982
155. SHERMAN RL, CHURG J, YUDIS M: Hereditary nephritis with a characteristic renal lesion. Am J Med 56:44-50, 1974
156. HILL GS, JENIS EH, GOODLOE SG: The nonspecificity of the ultrastructural alterations in hereditary nephritis. Lab Invest 31:516-532, 1974
157. ZOLLINGER HU, MIHTASCH MJ: Renal Pathology in Biopsy. New York, Springer-Verlag, 1978
158. HABIB R, GUBLER MC, HINGLAIS N, NOEL LH, DROZ D, LEVY M, MAHIEU P, FOIDART JM, PERRIN D, BOIS E, GRUNFELD JP: Alport's syndrome: Experience at Hopital Necker. Kidney Int 21(Suppl 11): S20-S28, 1982
159. KOHAUT EC, SINGER DB, NEVELS BK, HILL L: The specificity of split renal membranes in hereditary nephritis. Arch Pathol Lab Med 100:475-479, 1976
160. FARBOODY GH, VALENZUELA R, MCCORMACK LJ, KALLAEN R, OSBORNE DG: Chronic hereditary nephritis: A clinicopathologic study of 23 new kindreds and review of the literature. Hum Pathol 10:655-668, 1979
161. GRUNFELD J-P, BOIS EP, HINGLAIS N: Progressive and non-progressive hereditary nephritis. Kidney Int 4:216-228, 1973
162. YOSHIKAWA N, HASHIMOTO H, KATAYAMA Y, YAMADA Y, MATSUO T: The thin glomerular basement membrane in children with hematuria. J Pathol 142:253-257, 1984
163. TINA L, JENIS E, JOSE P, MEDANI C, PAPADOPOULOU Z, CALCAGNO P: The glomerular basement membrane in benign familial hematuria. Clin Nephrol 17:1-4, 1982
164. ROGERS PW, KURTZMAN NA, BUNN SM, WHITE MG: Familial benign essential hematuria. Arch Intern Med 131:257-262, 1973
165. SCHROEDER CH, LEMMINK HH, SMEETS HJM, NILLESEN WN, JEFFERSON JA, BRUNNER HG, MONNENS LAH: Familial benign hematuria is linked to the α3 and α4 type IV collagen genes. J Am Soc Nephrol 6:727, 1995
166. SCHRODER CH, BONTEMPS CM, ASSMANN KJM, SCHUURMANS-STEKHOVEN JH, FOIDART JM, MONNENS LAH, VEERKAMP JH: Renal biopsy and family studies in 65 children with isolated hematuria. Acta Paediatr Scand 79:630-636, 1990
167. PETTERSSON E, TORNROTH T, WIESLANDER J: Abnormally thin glomerular basement membrane and the Goodpasture epitope. Clin Nephrol 33:105-109, 1990
168. KIM KH, KIM Y, GUBLER MC, STEFFES MW, LANE PH, KASHTAN CE, CROSSON JT, MAUER SM: Structure-functional relationships in Alport syndrome. J Am Soc Nephrol 5:1659-1668, 1995
169. YOSHIKAWA N, ITO H, MATSUYAMA S, HAJIKANO H, OKADA S, MATSUO T: Hereditary nephritis in children with and without characterstic glomerular basement membrane alterations. Clin Nephrol 30:122-127, 1988
170. DING J, KASHTAN CE, FAN WW, KLEPPEL MM, SUN MJ, KALLURI R, NEILSON EG, MICHAEL AF: A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the α5 chain of type IV collagen. Kidney Int 45:1504-1506, 1994
171. KLEPPEL MM, FAN W, CHEONG H, KASHTAN CE, MICHAEL AF: Immunochemical studies of the Alport antigen. Kidney Int 41:1629-1637, 1992
172. TURCO AE, ROSSETTI S, BRESIN E, CORRA S: Erroneous genetic risk assessment of Alport syndrome. Lancet 346:1237, 1995
173. GOBEL J, OLBRICHT CJ, OFFNER G, HELMCHEN U, REPP H, KOCH KM, FREI U: Kidney transplantation in Alport's syndrome: Long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 38: 299-304, 1992
174. PETEN E, PIRSON Y, COSYNS J-P, SQUIFFLET J-P, ALEXANDRE GPJ, NOEL L-H, GRUNFELD J-P, VAN YPERSELE DE STRIHOU C: Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 52:823-826, 1991
175. VAN DE HEUVEL LPWJ, SCHRODER CH, SAVAGE COS, MENZEL D, ASSMANN KJM, MONNENS LAH, VEERKAMP JH: The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: Characterization of the antibody target. Pediatr Nephrol 3:406-413, 1989
176. KASHTAN CE, MCENERY PT, TEJANI A, STABLEIN DM: Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9:679-684, 1995
177. OLIVER TB, GOULDESBROUGH DR, SWAINSON CP: Acute crescentic glomerulonephritis associated with antiglomerular basement membrane antibody in Alport's syndrome after second transplantation. Nephrol Dial Transplant 6:893-895, 1991
178. KASHTAN C, BUTKOWSKI R, KLEPPEL M, FIRST M, MICHAEL A: Posttransplant anti-glomerular basement membrane nephritis in related Alport males with Alport syndrome. J Lab Clin Med 116:508-515, 1990
179. HUDSON BG, KALLURI R, GUNWAR S, WEBER M, BALLESTER F, HUDSON JK, NEOLKEN ME, SARRAS M, RICHARDSON WR, SAUS J, ABRAHAMSON DR, GLICK AD, HARALSON MA, HELDERMAN JH, STONE WJ, JACOBSON HR: The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: Evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42:179-187, 1992
180. KASHTAN C, BUTKOWSKI R, KLEPPEL M, FIRST M, MICHAEL A: Posttransplant anti-glomerular basement membrane nephritis in related Alport males with Alport syndrome. J Lab Clin Med 116:508-515, 1990
181. NETZER K, PULLIG O, RENDERS L, GOBEL J, FREI U, TRYGGVASON K, WEBER M: Analysis of the COL4A5 gene in patients with Alport syndrome and post-transplant antiglomerular basement membrane disease. (abstract) Nephrol Dial Transplant 7:784, 1992
182. DING J, ZHOU J, TRYGGVASON K, KASHTAN CE: COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:161-168, 1994
183. KNEBELMANN B, ANTIGNAC C, GUBLER M-C, GRUNFELD J-P: A molecular approach to inherited kidney disorders. Kidney Int 44: 1205-1216, 1993
184. MILLINER DS, PIEREDES AN, HOLLEY KE: Renal transplantation in Alport's syndrome: Anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57:35-43, 1982
185. SESSA A, PIETRUCCI A, CAROZZI S, TARELLI LT, TAZZARI S, GIORDANO F, MERONI M, BARRINI G, VALENTE U, RENIERI A, DE MARCHI M: Renal transplantation from living donor parents in two brothers with Alport syndrome. Nephron 70:106-109, 1995
186. HEIKKILA P, PARPALA T, LUKKARINEN O, WEBER M, TRYGGVASON K: Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system-First step towards gene therapy of Alport syndrome. Gene Therapy 3:21-27, 1996